Possible takeover: What makes Qiagen so attractive to financial investors
Investor EQT is apparently bidding for biotech company Qiagen, a competitor is holding out. After the crisis, the laboratory business is offering potential again.
We haven't written up this one. Handelsblatt has the full story — the link below goes straight to it.